EUCTR2016-001092-74-LV进行中（未招募）1 期
Pharmacodynamics of antidiabetic drug metformin - MIKROMET
atvian Biomedical Research and Study centre0 个研究点开始时间: 2017年3月27日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Age: 18 – 64 years;
- •2. Caucasian race;
- •3. Have given written informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 50
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Allergies to any of Metforal 850mg components;
- •2. Usage of any other medicaments which are not compatible with metformin;
- •3. Pregnancy or lactation;
- •4. Current gastrointestinal, autoimmune, oncological or kidney diseases;
- •5. Current other health conditions which do not allow to use metformin (e.g.);
- •6. Usage of following medications in the past two months:
- •a. Antibiotics
- •b. Probiotics as coated tablets/capsules
- •c. Immunosuppressive medicaments (e.g. Methotrexate)
- •d. Corticosteroids (e.g. Cortisone, Hydrocortisone, Prednisolone);
- •e. Proton pump inhibitors (e.g. Gasec, Lomac, Gastrocaps);
- •7. Diarrhea in the past week;
- •8. Previous metformin administration.
研究者
相似试验
已完成
不适用
Pharmacokinetics and Pharmacodynamics of metformin in patients with type 2 diabetes and renal impairmentDiabetic NephropathyNL-OMON38577niversitair Medisch Centrum Groningen110
已完成
不适用
A study of factors affecting the concentrations of metformin in type 2 diabetic patientsType 2 diabetesMetabolic and Endocrine - DiabetesACTRN12611000908932Prof Richard Day120
已完成
1 期
The use of metformin in patients with moderate to severe renal failure and type 2 diabetesType 2 Diabetes mellitusMetabolic and Endocrine - DiabetesRenal and Urogenital - Kidney diseaseChronic Kidney DiseaseACTRN12616001248459Dr Ajith Dissanayake18
已完成
4 期
The safety and disposition of metformin in people with liver diseaseChronic liver diseaseMetabolic and Endocrine - DiabetesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12619001292167St Vincent's Hospital, Sydney24
已完成
不适用
The safety and disposition of metformin in people with liver disease and diabetes already treated with metformiChronic liver diseaseMetabolic and Endocrine - DiabetesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonDiabetesACTRN12619001348145St Vincent's Hospital, Sydney34